vs
艾伯维（ABBV）与Ardent Health, Inc.（ARDT）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Ardent Health, Inc.的10.4倍（$16.6B vs $1.6B）。艾伯维净利率更高（10.9% vs 2.8%，领先8.1%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
Goodlife Health Clubs是一家健身俱乐部连锁品牌，在澳大利亚拥有超过80家门店，是当地颇具规模的健身服务提供商，为消费者提供专业的健身场地、器械及相关健身体验服务。
ABBV vs ARDT — 直观对比
营收规模更大
ABBV
是对方的10.4倍
$1.6B
净利率更高
ABBV
高出8.1%
2.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $16.6B | $1.6B |
| 净利润 | $1.8B | $45.0M |
| 毛利率 | 72.6% | — |
| 营业利润率 | 27.3% | 5.8% |
| 净利率 | 10.9% | 2.8% |
| 营收同比 | 10.0% | — |
| 净利润同比 | 8354.5% | — |
| 每股收益（稀释后） | $1.02 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVARDT
| Q4 25 | $16.6B | $1.6B | ||
| Q3 25 | $15.8B | $1.6B | ||
| Q2 25 | $15.4B | $1.6B | ||
| Q1 25 | $13.3B | $1.5B | ||
| Q4 24 | $15.1B | — | ||
| Q3 24 | $14.5B | $1.4B | ||
| Q2 24 | $14.5B | $1.5B | ||
| Q1 24 | $12.3B | — |
净利润ABBVARDT
| Q4 25 | $1.8B | $45.0M | ||
| Q3 25 | $186.0M | $-23.5M | ||
| Q2 25 | $938.0M | $73.0M | ||
| Q1 25 | $1.3B | $41.4M | ||
| Q4 24 | $-22.0M | — | ||
| Q3 24 | $1.6B | $26.3M | ||
| Q2 24 | $1.4B | $42.8M | ||
| Q1 24 | $1.4B | — |
毛利率ABBVARDT
| Q4 25 | 72.6% | — | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | — | ||
| Q1 25 | 70.0% | — | ||
| Q4 24 | 70.9% | — | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | — | ||
| Q1 24 | 66.7% | — |
营业利润率ABBVARDT
| Q4 25 | 27.3% | 5.8% | ||
| Q3 25 | 12.1% | -0.1% | ||
| Q2 25 | 31.7% | 7.4% | ||
| Q1 25 | 28.0% | 5.0% | ||
| Q4 24 | -9.9% | — | ||
| Q3 24 | 26.5% | 3.9% | ||
| Q2 24 | 27.6% | 5.6% | ||
| Q1 24 | 22.7% | — |
净利率ABBVARDT
| Q4 25 | 10.9% | 2.8% | ||
| Q3 25 | 1.2% | -1.5% | ||
| Q2 25 | 6.1% | 4.4% | ||
| Q1 25 | 9.6% | 2.8% | ||
| Q4 24 | -0.1% | — | ||
| Q3 24 | 10.8% | 1.8% | ||
| Q2 24 | 9.5% | 2.9% | ||
| Q1 24 | 11.1% | — |
每股收益（稀释后）ABBVARDT
| Q4 25 | $1.02 | $0.32 | ||
| Q3 25 | $0.10 | $-0.17 | ||
| Q2 25 | $0.52 | $0.52 | ||
| Q1 25 | $0.72 | $0.29 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.88 | $0.19 | ||
| Q2 24 | $0.77 | $0.34 | ||
| Q1 24 | $0.77 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.3B | $709.6M |
| 总债务越低越好 | $58.9B | $1.1B |
| 股东权益账面价值 | $-3.3B | $1.3B |
| 总资产 | $134.0B | $5.3B |
| 负债/权益比越低杠杆越低 | — | 0.84× |
8季度趋势，按日历期对齐
现金及短期投资ABBVARDT
| Q4 25 | $5.3B | $709.6M | ||
| Q3 25 | $5.7B | $609.4M | ||
| Q2 25 | $6.5B | $540.6M | ||
| Q1 25 | $5.2B | $495.0M | ||
| Q4 24 | $5.6B | — | ||
| Q3 24 | $7.3B | $563.1M | ||
| Q2 24 | $13.2B | $334.5M | ||
| Q1 24 | $18.1B | — |
总债务ABBVARDT
| Q4 25 | $58.9B | $1.1B | ||
| Q3 25 | $63.0B | $1.1B | ||
| Q2 25 | $63.0B | $1.1B | ||
| Q1 25 | $64.5B | $1.1B | ||
| Q4 24 | $60.3B | — | ||
| Q3 24 | $58.5B | $1.1B | ||
| Q2 24 | $58.0B | $1.1B | ||
| Q1 24 | $63.8B | — |
股东权益ABBVARDT
| Q4 25 | $-3.3B | $1.3B | ||
| Q3 25 | $-2.6B | $1.2B | ||
| Q2 25 | $-183.0M | $1.3B | ||
| Q1 25 | $1.4B | $1.2B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $6.0B | $1.0B | ||
| Q2 24 | $6.8B | $739.9M | ||
| Q1 24 | $8.0B | — |
总资产ABBVARDT
| Q4 25 | $134.0B | $5.3B | ||
| Q3 25 | $133.9B | $5.2B | ||
| Q2 25 | $137.2B | $5.0B | ||
| Q1 25 | $136.2B | $4.9B | ||
| Q4 24 | $135.2B | — | ||
| Q3 24 | $143.4B | $4.8B | ||
| Q2 24 | $141.9B | $4.6B | ||
| Q1 24 | $148.9B | — |
负债/权益比ABBVARDT
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.88× | ||
| Q2 25 | — | 0.87× | ||
| Q1 25 | 45.44× | 0.93× | ||
| Q4 24 | 18.15× | — | ||
| Q3 24 | 9.70× | 1.08× | ||
| Q2 24 | 8.56× | 1.46× | ||
| Q1 24 | 7.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.2B | $223.4M |
| 自由现金流经营现金流 - 资本支出 | $4.9B | — |
| 自由现金流率自由现金流/营收 | 29.4% | — |
| 资本支出强度资本支出/营收 | 2.0% | — |
| 现金转化率经营现金流/净利润 | 2.87× | 4.97× |
| 过去12个月自由现金流最近4个季度 | $17.8B | — |
8季度趋势，按日历期对齐
经营现金流ABBVARDT
| Q4 25 | $5.2B | $223.4M | ||
| Q3 25 | $7.0B | $154.4M | ||
| Q2 25 | $5.2B | $117.5M | ||
| Q1 25 | $1.6B | $-24.8M | ||
| Q4 24 | $7.0B | — | ||
| Q3 24 | $5.4B | $89.7M | ||
| Q2 24 | $2.3B | — | ||
| Q1 24 | $4.0B | — |
自由现金流ABBVARDT
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $6.8B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | — | ||
| Q1 24 | $3.8B | — |
自由现金流率ABBVARDT
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 44.7% | — | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | 31.3% | — |
资本支出强度ABBVARDT
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 1.6% | — |
现金转化率ABBVARDT
| Q4 25 | 2.87× | 4.97× | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | 1.61× | ||
| Q1 25 | 1.27× | -0.60× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.49× | 3.41× | ||
| Q2 24 | 1.66× | — | ||
| Q1 24 | 2.95× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
